Dr. Armine Smith discusses the importance of personalized therapeutic approaches for the treatment of urologic cancers, such ...

She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients ...

Treatment with givinostat has received fast track designation from the United States Food and Drug Administration for ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

Dr. Cathy Eng discusses data that led to the FDA approval of Braftovi and Erbitux plus chemo for metastatic colorectal cancer ...

Michi has been an oncology nurse for more than 20 years and continues to make an impact in the field. Michi has expertise in ...

Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment ...

Dr. Shirley D'Sa discusses the importance of catching peripheral neuropathy in patients with Waldenstrom macroglobulinemia ...

Discrepancies between patients' experiences and friends' lives can strain relationships, highlighting the need for ...

An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming ...

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

Panelists discuss how to communicate genomic testing results to patients and make shared treatment decisions, particularly when multiple targeted therapy options are available for patients with ESR1 ...